BSE Live
Oct 30, 16:01Prev. Close
873.10
Open Price
878.90
Bid Price (Qty.)
862.45 (22)
Offer Price (Qty.)
862.45 (2)
NSE Live
Oct 25, 15:57Prev. Close
689.35
Open Price
691.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
672.25 (249)
| Key Financial Ratios of Novartis India (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 40.87 | 34.50 | 41.86 | -1.51 | 8.46 | |
| Diluted EPS (Rs.) | 40.87 | 34.50 | 41.86 | -1.51 | 8.46 | |
| Cash EPS (Rs.) | 41.77 | 35.58 | 44.34 | 2.40 | 13.40 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 318.06 | 301.79 | 314.29 | 280.27 | 288.16 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 318.06 | 301.79 | 314.29 | 280.27 | 288.16 | |
| Dividend / Share(Rs.) | 25.00 | 25.00 | 47.50 | 10.00 | 10.00 | |
| Revenue from Operations/Share (Rs.) | 144.36 | 135.77 | 153.46 | 162.02 | 154.52 | |
| PBDIT/Share (Rs.) | 54.04 | 51.43 | 49.91 | 24.43 | 24.26 | |
| PBIT/Share (Rs.) | 53.16 | 50.38 | 47.46 | 20.52 | 19.34 | |
| PBT/Share (Rs.) | 52.84 | 49.77 | 46.75 | -1.55 | 16.22 | |
| Net Profit/Share (Rs.) | 40.88 | 34.52 | 41.88 | -1.51 | 8.47 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 37.43 | 37.88 | 32.52 | 15.07 | 15.70 | |
| PBIT Margin (%) | 36.82 | 37.10 | 30.92 | 12.66 | 12.51 | |
| PBT Margin (%) | 36.60 | 36.66 | 30.46 | -0.95 | 10.49 | |
| Net Profit Margin (%) | 28.32 | 25.42 | 27.29 | -0.93 | 5.48 | |
| Return on Networth / Equity (%) | 12.85 | 11.43 | 13.32 | -0.53 | 2.93 | |
| Return on Capital Employed (%) | 16.28 | 16.19 | 14.22 | 6.83 | 5.65 | |
| Return on Assets (%) | 10.64 | 9.21 | 10.51 | -0.38 | 2.08 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 0.38 | 0.35 | 0.39 | 0.41 | 0.37 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 5.25 | 4.45 | 4.25 | 3.27 | 4.56 | |
| Quick Ratio (X) | 4.96 | 4.16 | 3.90 | 3.01 | 4.25 | |
| Inventory Turnover Ratio (X) | 8.29 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 61.17 | 137.66 | 23.88 | -663.70 | 118.13 | |
| Dividend Payout Ratio (CP) (%) | 59.87 | 133.57 | 22.56 | 416.35 | 74.68 | |
| Earnings Retention Ratio (%) | 38.83 | -37.66 | 76.12 | 763.70 | -18.13 | |
| Cash Earnings Retention Ratio (%) | 40.13 | -33.57 | 77.44 | -316.35 | 25.32 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 1,289.47 | 1,942.40 | 839.22 | 939.60 | 863.46 | |
| EV/Net Operating Revenue (X) | 3.62 | 5.80 | 2.22 | 2.35 | 2.26 | |
| EV/EBITDA (X) | 9.67 | 15.30 | 6.81 | 15.58 | 14.42 | |
| MarketCap/Net Operating Revenue (X) | 5.44 | 7.58 | 3.68 | 3.64 | 3.57 | |
| Retention Ratios (%) | 38.82 | -37.66 | 76.11 | 763.70 | -18.13 | |
| Price/BV (X) | 2.47 | 3.41 | 1.80 | 2.11 | 1.92 | |
| Price/Net Operating Revenue | 5.44 | 7.58 | 3.68 | 3.64 | 3.57 | |
| Earnings Yield | 0.05 | 0.03 | 0.07 | 0.00 | 0.02 | 
29.10.2025
30.07.2025
Novartis India Standalone June 2025 Net Sales at Rs 87.55 crore, down 5.14% Y-o-Y
30.07.2025
29.01.2025
Novartis India Standalone December 2024 Net Sales at Rs 93.00 crore, up 10.01% Y-o-Y
30.07.2025
Novartis India Standalone June 2025 Net Sales at Rs 87.55 crore, down 5.14% Y-o-Y
29.01.2025
Novartis India Standalone December 2024 Net Sales at Rs 93.00 crore, up 10.01% Y-o-Y
28.10.2024
Novartis India Standalone September 2024 Net Sales at Rs 87.10 crore, up 10.59% Y-o-Y
29.07.2024
Novartis India Standalone June 2024 Net Sales at Rs 92.29 crore, up 1.87% Y-o-Y